We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
-28.15%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$77.1M
AUM Growth
-$58.2M
Cap. Flow
-$7.2M
Cap. Flow %
-9.33%
Top 10 Hldgs %
97.81%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$4.77M
2
SLN
Silence Therapeutics
SLN
+$2.43M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.2B
$30.8M 39.88%
6,164,548
-835,452
-12% -$4.77M
IVVD icon
2
Invivyd
IVVD
$218M
$10.2M 13.19%
9,248,250
– –
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$394M
$8.3M 10.76%
385,680
– –
GUTS icon
4
Fractyl Health
GUTS
$111M
$7.93M 10.27%
1,856,117
– –
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$4.16M 5.39%
110,400
– –
SLN
6
Silence Therapeutics
SLN
$564M
$3.52M 4.56%
185,100
-114,300
-38% -$2.43M
BBIO icon
7
BridgeBio Pharma
BBIO
$16.5B
$3.07M 3.98%
121,200
– –
CRIS icon
8
Curis
CRIS
$7.83M
$2.91M 3.77%
21,098
– –
TGTX icon
9
TG Therapeutics
TGTX
$7.62B
$2.87M 3.73%
161,600
– –
ARWR icon
10
Arrowhead Research
ARWR
$12.4B
$1.75M 2.27%
67,400
– –
PRQR icon
11
ProQR Therapeutics
PRQR
$265M
$1.69M 2.19%
1,019,498
– –

Similar funds

NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return
FRGX
First Reserve GP XIII Stamford, Connecticut $52.9M AUM 17.37% 1-Year Est. Return

M28 Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M28 Capital Management held 11 positions worth $77.1M, down 43% from $135M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

M28 Capital Management withdrew a net $7.2M in Q2 2024, reducing 2 holdings. Its largest reduction was Wave Life Sciences, cutting an estimated $4.77M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management's biggest Q2 2024 reduction was Wave Life Sciences, cutting an estimated $4.77M.
  • M28 Capital Management's ten largest holdings make up 98% of its $77.1M portfolio in Q2 2024.
  • M28 Capital Management opened 0 new positions and closed 0 in Q2 2024.
  • M28 Capital Management's portfolio value fell 43% quarter-over-quarter to $77.1M.

Based on M28 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.